Education
About Us
Working with TipRanks
Follow Us
Matthew Gline Insider Profile
4 Followers
Matthew Gline, CEO, Director at Roivant Sciences, holds 17.29M shares in Roivant Sciences (Ticker: ROIV). Most recently, Matthew Gline Bought 3,315 shares of Roivant Sciences on Sep 18, 2025 for an estimated value of $49.96K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-52.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Matthew Gline holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Gline
Matthew Gline's Trading History
List of latest transactions for each holding click on a transaction to see Matthew Gline's performance on stock
You May Also Like
Matthew Gline insider profile FAQ
What is the percentage of profitable transactions made by Matthew Gline?
The percentage of profitable transactions made by Matthew Gline is 33%.
What is the average return per transaction made by Matthew Gline?
The average return per transaction made by Matthew Gline is -52.50%.
What stocks does Matthew Gline hold?
Matthew Gline holds: ROIV stocks.
What was Matthew Gline’s latest transaction?
Matthew Gline latest transaction was an Informative Buy of $49.96K.
What was Matthew Gline's most profitable transaction?
Matthew Gline’s most profitable transaction was an Informative Buy of ROIV stock on September 18, 2025. The return on the trade was 7.10%.
What is Matthew Gline's role in Roivant Sciences?
Matthew Gline's role in Roivant Sciences is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.